שווי כולל של החברה: iobiotech.com (IOBT)
IO Biotech, Inc. (IOBT) is implementing robotic systems to accelerate peptide analysis for cancer vaccine development, eliminating monotonous labor for scientists. The firm's strategy relies on patenting immunotherapeutic discoveries and maintaining long-term alliances with pharmaceutical behemoths. This Enterprise Value chart is fixed at -9.09. The company is currently completing the final stage of trials for its melanoma drug, paving the way for a full-scale product market launch.
IO Biotech, Inc. - פילוחים אנליטיים ומדדי מפתח (IOBT)
Enterprise Value (EV) represents the sum of market capitalization and net debt, reflecting the actual cost of a full business buyout minus liquid assets. For IO Biotech, Inc. (IOBT), where the reputational capital of Danish management ensures efficient resource management, the company's aggregate asset valuation allows for an objective correlation between the value of the clinical pipeline and real financial obligations.